Skip to main content

Table 1 Baseline characteristics of the study population

From: Associations of visit-to-visit variabilities and trajectories of serum lipids with the future probability of type 2 diabetes mellitus

Variables

All participants

Diabetes

Non-diabetes

t/χ2

P

Age (years)

50.39±7.98

52.12±7.03

50.30±8.02

3.32

0.001

Male (%)

3125 (69.83)

191 (85.65)

2934 (69.00)

27.87

< 0.001

Body mass index (kg/m2)

24.05±2.61

25.54±2.51

23.97±2.59

8.82

< 0.001

Smoking (%)

1551 (34.66)

118 (52.91)

1433 (33.70)

34.54

< 0.001

Drinking (%)

1759 (39.31)

97 (43.50)

1662 (39.09)

1.73

0.189

Hypertension (%)

568 (12.69)

56 (25.11)

512 (12.04)

33.67

< 0.001

Antihypertensive drugs therapy (%)

720 (16.09)

54 (24.22)

666 (15.66)

11.48

0.001

Systolic blood pressure (mmHg)

115.41±12.81

121.17±13.07

115.11±12.72

6.93

< 0.001

Diastolic blood pressure (mmHg)

75.64±9.39

80.52±9.73

75.38±9.30

8.02

< 0.001

FPG (mmol/L)

5.33±0.44

5.91±0.47

5.30±0.42

20.99

< 0.001

TG (mmol/L)

1.67±1.26

2.26±2.02

1.64±1.20

7.20

< 0.001

TC (mmol/L)

4.92±0.85

5.14±0.97

4.91±0.84

3.92

< 0.001

LDL-c (mmol/L)

3.04±0.76

3.26±0.86

3.03±0.75

4.37

< 0.001

HDL-c (mmol/L)

1.35±0.34

1.20±0.28

1.35±0.34

6.52

< 0.001